Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Identifieur interne : 002830 ( Main/Exploration ); précédent : 002829; suivant : 002831Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Auteurs : Jose A. Obeso [Espagne] ; Maria Cruz Rodríguez-Oroz [Espagne] ; Beatriz Benitez-Temino [Espagne] ; Franscisco J. Blesa [Espagne] ; Jorge Guridi [Espagne] ; Concepci Marin [Espagne] ; Manuel Rodriguez [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2008.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Afferent Pathways (pathology), Afferent Pathways (physiopathology), Animals, Antiparkinson Agents (therapeutic use), Basal Ganglia (anatomy & histology), Basal Ganglia (pathology), Basal Ganglia (physiopathology), Basal ganglion, Cerebral Cortex (pathology), Cerebral Cortex (physiopathology), Corpus Striatum (pathology), Corpus Striatum (physiopathology), Functional organization, Globus Pallidus (pathology), Globus Pallidus (physiopathology), Haplorhini, Humans, Models, Animal, Models, Neurological, Nervous system diseases, Neuron, Parkinson Disease (drug therapy), Parkinson Disease (pathology), Parkinson Disease (physiopathology), Parkinson disease, Subthalamic nucleus, Treatment, basal ganglia, globus pallidus, medium spiny neurons, parkinson's disease, striatum, subthalamic nucleus.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents.
- anatomy & histology : Basal Ganglia.
- drug therapy : Parkinson Disease.
- pathology : Afferent Pathways, Basal Ganglia, Cerebral Cortex, Corpus Striatum, Globus Pallidus, Parkinson Disease.
- physiopathology : Afferent Pathways, Basal Ganglia, Cerebral Cortex, Corpus Striatum, Globus Pallidus, Parkinson Disease.
- Animals, Haplorhini, Humans, Models, Animal, Models, Neurological.
Abstract
The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is the best understood anatomically and physiologically, and because Parkinson's disease is mainly thought to be a movement disorder. Normal function of the BG requires fine tuning of neuronal excitability within each nucleus to determine the exact degree of movement facilitation or inhibition at any given moment. This is mediated by the complex organization of the striatum, where the excitability of medium spiny neurons is controlled by several pre‐ and postsynaptic mechanisms as well as interneuron activity, and secured by several recurrent or internal BG circuits. The motor circuit of the BG has two entry points, the striatum and the subthalamic nucleus (STN), and an output, the globus pallidus pars interna (GPi), which connects to the cortex via the motor thalamus. Neuronal afferents coding for a given movement or task project to the BG by two different systems: (1) Direct disynaptic projections to the GPi via the striatum and STN. (2) Indirect trisynaptic projections to the GPi via the globus pallidus pars externa (GPe). Corticostriatal afferents primarily act to inhibit medium spiny neurons in the “indirect circuit” and facilitate neurons in the “direct circuit.” The GPe is in a pivotal position to regulate the motor output of the BG. Dopamine finely tunes striatal input as well as neuronal striatal activity, and modulates GPe, GPi, and STN activity. Dopaminergic depletion in Parkinson's disease disrupts the corticostriatal balance leading to increased activity the indirect circuit and reduced activity in the direct circuit. The precise chain of events leading to increased STN activity is not completely understood, but impaired dopaminergic regulation of the GPe, GPi, and STN may be involved. The parkinsonian state is characterized by disruption of the internal balance of the BG leading to hyperactivity in the two main entry points of the network (striatum and STN) and excessive inhibitory output from the GPi. Replacement therapy with standard levodopa creates a further imbalance, producing an abnormal pattern of neuronal discharge and synchronization of neuronal firing that sustain the “off” and “on with dyskinesia” states. The effect of levodopa is robust but short‐lasting and converts the parkinsonian BG into a highly unstable system, where pharmacological and compensatory effects act in opposing directions. This creates a scenario that substantially departs from the normal physiological state of the BG. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22062
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000192
- to stream Istex, to step Curation: 000192
- to stream Istex, to step Checkpoint: 001386
- to stream PubMed, to step Corpus: 002058
- to stream PubMed, to step Curation: 002058
- to stream PubMed, to step Checkpoint: 002280
- to stream Ncbi, to step Merge: 002305
- to stream Ncbi, to step Curation: 002305
- to stream Ncbi, to step Checkpoint: 002305
- to stream Main, to step Merge: 003408
- to stream PascalFrancis, to step Corpus: 001132
- to stream PascalFrancis, to step Curation: 001B87
- to stream PascalFrancis, to step Checkpoint: 001245
- to stream Main, to step Merge: 003853
- to stream Main, to step Curation: 002830
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease</title>
<author><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name>
</author>
<author><name sortKey="Rodriguez Roz, Maria Cruz" sort="Rodriguez Roz, Maria Cruz" uniqKey="Rodriguez Roz M" first="Maria Cruz" last="Rodríguez-Oroz">Maria Cruz Rodríguez-Oroz</name>
</author>
<author><name sortKey="Benitez Emino, Beatriz" sort="Benitez Emino, Beatriz" uniqKey="Benitez Emino B" first="Beatriz" last="Benitez-Temino">Beatriz Benitez-Temino</name>
</author>
<author><name sortKey="Blesa, Franscisco J" sort="Blesa, Franscisco J" uniqKey="Blesa F" first="Franscisco J." last="Blesa">Franscisco J. Blesa</name>
</author>
<author><name sortKey="Guridi, Jorge" sort="Guridi, Jorge" uniqKey="Guridi J" first="Jorge" last="Guridi">Jorge Guridi</name>
</author>
<author><name sortKey="Marin, Concepci" sort="Marin, Concepci" uniqKey="Marin C" first="Concepci" last="Marin">Concepci Marin</name>
</author>
<author><name sortKey="Rodriguez, Manuel" sort="Rodriguez, Manuel" uniqKey="Rodriguez M" first="Manuel" last="Rodriguez">Manuel Rodriguez</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FA9D3E3245AC0FCCE0E03EDF8714EACCBB2E3714</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22062</idno>
<idno type="url">https://api.istex.fr/document/FA9D3E3245AC0FCCE0E03EDF8714EACCBB2E3714/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000192</idno>
<idno type="wicri:Area/Istex/Curation">000192</idno>
<idno type="wicri:Area/Istex/Checkpoint">001386</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Obeso J:functional:organization:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18781672</idno>
<idno type="wicri:Area/PubMed/Corpus">002058</idno>
<idno type="wicri:Area/PubMed/Curation">002058</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002280</idno>
<idno type="wicri:Area/Ncbi/Merge">002305</idno>
<idno type="wicri:Area/Ncbi/Curation">002305</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002305</idno>
<idno type="wicri:Area/Main/Merge">003408</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0466159</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001132</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B87</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001245</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Obeso J:functional:organization:of</idno>
<idno type="wicri:Area/Main/Merge">003853</idno>
<idno type="wicri:Area/Main/Curation">002830</idno>
<idno type="wicri:Area/Main/Exploration">002830</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease</title>
<author><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology and Neurosurgery, Clinica Universitaria and Medical School and Neuroscience Centre, CIMA, University of Navarra, Pamplona</wicri:regionArea>
<wicri:noRegion>Pamplona</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="no comma">Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rodriguez Roz, Maria Cruz" sort="Rodriguez Roz, Maria Cruz" uniqKey="Rodriguez Roz M" first="Maria Cruz" last="Rodríguez-Oroz">Maria Cruz Rodríguez-Oroz</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology and Neurosurgery, Clinica Universitaria and Medical School and Neuroscience Centre, CIMA, University of Navarra, Pamplona</wicri:regionArea>
<wicri:noRegion>Pamplona</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="no comma">Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Benitez Emino, Beatriz" sort="Benitez Emino, Beatriz" uniqKey="Benitez Emino B" first="Beatriz" last="Benitez-Temino">Beatriz Benitez-Temino</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology and Neurosurgery, Clinica Universitaria and Medical School and Neuroscience Centre, CIMA, University of Navarra, Pamplona</wicri:regionArea>
<wicri:noRegion>Pamplona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Blesa, Franscisco J" sort="Blesa, Franscisco J" uniqKey="Blesa F" first="Franscisco J." last="Blesa">Franscisco J. Blesa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology and Neurosurgery, Clinica Universitaria and Medical School and Neuroscience Centre, CIMA, University of Navarra, Pamplona</wicri:regionArea>
<wicri:noRegion>Pamplona</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="no comma">Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Guridi, Jorge" sort="Guridi, Jorge" uniqKey="Guridi J" first="Jorge" last="Guridi">Jorge Guridi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology and Neurosurgery, Clinica Universitaria and Medical School and Neuroscience Centre, CIMA, University of Navarra, Pamplona</wicri:regionArea>
<wicri:noRegion>Pamplona</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="no comma">Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Marin, Concepci" sort="Marin, Concepci" uniqKey="Marin C" first="Concepci" last="Marin">Concepci Marin</name>
<affiliation><wicri:noCountry code="no comma">Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3"><country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<wicri:orgArea>Laboratori de Neurologia Experimental, Àrea de Neurociències, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez, Manuel" sort="Rodriguez, Manuel" uniqKey="Rodriguez M" first="Manuel" last="Rodriguez">Manuel Rodriguez</name>
<affiliation><wicri:noCountry code="no comma">Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Neurobiology and Experimental Neurology Laboratory, Department of Physiology, Medical School,University of La Laguna, Tenerife</wicri:regionArea>
<wicri:noRegion>Tenerife</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008">2008</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">S3</biblScope>
<biblScope unit="supplement">S3</biblScope>
<biblScope unit="page" from="S548">S548</biblScope>
<biblScope unit="page" to="S559">S559</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">FA9D3E3245AC0FCCE0E03EDF8714EACCBB2E3714</idno>
<idno type="DOI">10.1002/mds.22062</idno>
<idno type="ArticleID">MDS22062</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Afferent Pathways (pathology)</term>
<term>Afferent Pathways (physiopathology)</term>
<term>Animals</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Basal Ganglia (anatomy & histology)</term>
<term>Basal Ganglia (pathology)</term>
<term>Basal Ganglia (physiopathology)</term>
<term>Basal ganglion</term>
<term>Cerebral Cortex (pathology)</term>
<term>Cerebral Cortex (physiopathology)</term>
<term>Corpus Striatum (pathology)</term>
<term>Corpus Striatum (physiopathology)</term>
<term>Functional organization</term>
<term>Globus Pallidus (pathology)</term>
<term>Globus Pallidus (physiopathology)</term>
<term>Haplorhini</term>
<term>Humans</term>
<term>Models, Animal</term>
<term>Models, Neurological</term>
<term>Nervous system diseases</term>
<term>Neuron</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson disease</term>
<term>Subthalamic nucleus</term>
<term>Treatment</term>
<term>basal ganglia</term>
<term>globus pallidus</term>
<term>medium spiny neurons</term>
<term>parkinson's disease</term>
<term>striatum</term>
<term>subthalamic nucleus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomy & histology" xml:lang="en"><term>Basal Ganglia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Afferent Pathways</term>
<term>Basal Ganglia</term>
<term>Cerebral Cortex</term>
<term>Corpus Striatum</term>
<term>Globus Pallidus</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Afferent Pathways</term>
<term>Basal Ganglia</term>
<term>Cerebral Cortex</term>
<term>Corpus Striatum</term>
<term>Globus Pallidus</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Haplorhini</term>
<term>Humans</term>
<term>Models, Animal</term>
<term>Models, Neurological</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Neurone</term>
<term>Noyau gris central</term>
<term>Noyau sousthalamique</term>
<term>Organisation fonctionnelle</term>
<term>Pathologie du système nerveux</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is the best understood anatomically and physiologically, and because Parkinson's disease is mainly thought to be a movement disorder. Normal function of the BG requires fine tuning of neuronal excitability within each nucleus to determine the exact degree of movement facilitation or inhibition at any given moment. This is mediated by the complex organization of the striatum, where the excitability of medium spiny neurons is controlled by several pre‐ and postsynaptic mechanisms as well as interneuron activity, and secured by several recurrent or internal BG circuits. The motor circuit of the BG has two entry points, the striatum and the subthalamic nucleus (STN), and an output, the globus pallidus pars interna (GPi), which connects to the cortex via the motor thalamus. Neuronal afferents coding for a given movement or task project to the BG by two different systems: (1) Direct disynaptic projections to the GPi via the striatum and STN. (2) Indirect trisynaptic projections to the GPi via the globus pallidus pars externa (GPe). Corticostriatal afferents primarily act to inhibit medium spiny neurons in the “indirect circuit” and facilitate neurons in the “direct circuit.” The GPe is in a pivotal position to regulate the motor output of the BG. Dopamine finely tunes striatal input as well as neuronal striatal activity, and modulates GPe, GPi, and STN activity. Dopaminergic depletion in Parkinson's disease disrupts the corticostriatal balance leading to increased activity the indirect circuit and reduced activity in the direct circuit. The precise chain of events leading to increased STN activity is not completely understood, but impaired dopaminergic regulation of the GPe, GPi, and STN may be involved. The parkinsonian state is characterized by disruption of the internal balance of the BG leading to hyperactivity in the two main entry points of the network (striatum and STN) and excessive inhibitory output from the GPi. Replacement therapy with standard levodopa creates a further imbalance, producing an abnormal pattern of neuronal discharge and synchronization of neuronal firing that sustain the “off” and “on with dyskinesia” states. The effect of levodopa is robust but short‐lasting and converts the parkinsonian BG into a highly unstable system, where pharmacological and compensatory effects act in opposing directions. This creates a scenario that substantially departs from the normal physiological state of the BG. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><country name="Espagne"><noRegion><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name>
</noRegion>
<name sortKey="Benitez Emino, Beatriz" sort="Benitez Emino, Beatriz" uniqKey="Benitez Emino B" first="Beatriz" last="Benitez-Temino">Beatriz Benitez-Temino</name>
<name sortKey="Blesa, Franscisco J" sort="Blesa, Franscisco J" uniqKey="Blesa F" first="Franscisco J." last="Blesa">Franscisco J. Blesa</name>
<name sortKey="Guridi, Jorge" sort="Guridi, Jorge" uniqKey="Guridi J" first="Jorge" last="Guridi">Jorge Guridi</name>
<name sortKey="Marin, Concepci" sort="Marin, Concepci" uniqKey="Marin C" first="Concepci" last="Marin">Concepci Marin</name>
<name sortKey="Rodriguez Roz, Maria Cruz" sort="Rodriguez Roz, Maria Cruz" uniqKey="Rodriguez Roz M" first="Maria Cruz" last="Rodríguez-Oroz">Maria Cruz Rodríguez-Oroz</name>
<name sortKey="Rodriguez, Manuel" sort="Rodriguez, Manuel" uniqKey="Rodriguez M" first="Manuel" last="Rodriguez">Manuel Rodriguez</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002830 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002830 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:FA9D3E3245AC0FCCE0E03EDF8714EACCBB2E3714 |texte= Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |